Annual report pursuant to Section 13 and 15(d)

License Agreement (Details Narrative)

v3.22.2.2
License Agreement (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
May 11, 2021
May 31, 2021
May 31, 2020
Jun. 30, 2020
Jun. 30, 2022
Jun. 30, 2021
Research and development expense         $ 2,961,538 $ 2,269,998
IPO [Member]            
Number of shares of common stock 3,078,224          
Vernalis Development Limited [Member] | License Agreement [Member]            
Research and development expense       $ 150,000    
Development milestone payment     $ 29,900,000      
Vernalis Development Limited [Member] | License Agreement [Member] | IPO [Member]            
Number of shares of common stock   192,857        
Future milestone payments   $ 1,350,000        
Vernalis Development Limited [Member] | License Agreement [Member] | Minimum [Member]            
Marketing authorization amount     350,000      
Sales milestone payments     10,000,000      
Cumulative annual net sales amount     500,000,000      
Vernalis Development Limited [Member] | License Agreement [Member] | Maximum [Member]            
Marketing authorization amount     3,000,000      
Sales milestone payments     25,000,000      
Cumulative annual net sales amount     $ 1,000,000,000